“
TL;DR
Limitations include the need for more in vivo studies in non-rodent models and elucidation of molecular mechanisms in specific diseases.
Acta Biochimica et Biophysica Sinica · 3 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Limitations include the need for more in vivo studies in non-rodent models and elucidation of molecular mechanisms in specific diseases.
Limitations include the need for more in vivo studies in non-rodent models and elucidation of molecular mechanisms in specific diseases. Implications suggest that targeting KLF7 expression could be a therapeutic strategy for neurological diseases, obesity, diabetes, and certain cancers, but clinical application requires further evaluation.